Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
2 other identifiers
observational
40
1 country
1
Brief Summary
To develop and test liver cancer prevention educational material.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 9, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
ExpectedMarch 4, 2026
March 1, 2026
12 months
May 9, 2025
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive Testing
Participant comprehension will be measured qualitatively through cognitive testing. In cognitive testing interviews, participants are asked to "think aloud" as they review and react to new information. Participants will be presented with the storyboard (mock-up) versions of the content and asked to describe in their own words what the information means to them. Cognitive interviews may include questions about content such as length, clarity of the language, and helpfulness of the educational material. A trained research team member will ask probing questions throughout interviews as needed. Based on patient feedback, modifications will be made iteratively to the content to ensure the content is understood and interpreted as intended. There is no post-survey for cognitive testing.
Up to 1.5 hours
Usability Testing
Usability will be measured qualitatively using a Usability Interview Guide. Usability will also be measured using the System Usability Scale. Acceptability will be measured with the Ottawa Acceptability Measures. Knowledge will be measured pre- and post- session using knowledge questions developed by the investigators and refined during cognitive testing.
Up to 1.5 hours
Study Arms (2)
Cognitive Interviews (English and Spanish)
Participants that agree to this part of the study will be asked to view patient education materials about liver cancer, complete a demographic survey, and do an interview one-on-one either online via Zoom, over the phone, or in person at HOPE Clinic.
Usability Testing (English and Spanish)
Participants will be asked to complete a pre-survey, navigate a liver cancer education website, provide their feedback and impressions, and complete a post- survey.
Interventions
Given by surveys and one-on-one interview.
Given by Survey and one-on one interviews
Eligibility Criteria
Participants at HOPE Clinic
You may qualify if:
- At least 18 years old
- Participants at the HOPE Clinic
- Able to speak and read either English or Spanish
- For usability testing: Able to use and navigate websites on own smart phone or study computer
You may not qualify if:
- Has been diagnosed with liver cancer
- Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Hwang, MD, MPH
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2025
First Posted
June 8, 2025
Study Start
May 1, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
April 30, 2027
Last Updated
March 4, 2026
Record last verified: 2026-03